NAMS MENOPAUSE CERIFICATION EXAM
COMPREHENSIVE REVIEW | 2026/2027
WITH ACTUAL QUESTIONS AND VERIFIED
DETAILED ANSWERS|100% CORRECT
|ALREADY GRADED A
JW, a 53-year-old post-menopausal female, presents to the pharmacy with a new prescription for
17β- estradiol topical gel (EstroGel) for vasomotor symptom relief.
Which of the following is the appropriate administration of 17β- estradiol topical gel (EstroGel)?
A. Apply 1 pump depression once daily to one arm from wrist to shoulder
B. Apply 1 pump depression once daily to one upper arm and shoulder area
C. Apply 1 packet once daily to one upper thigh
D. Apply 1 pouch once daily to each thigh and calf
A.
JW, a 53-year-old post-menopausal female, presents to the pharmacy with a new prescription for
17β- estradiol topical gel (EstroGel) for vasomotor symptom relief.
Which statement should be included in the counseling for 17β- estradiol topical gel (EstroGel)?
, NAMS MENOPAUSE CERIFICATION EXAM
COMPREHENSIVE REVIEW | 2026/2027
WITH ACTUAL QUESTIONS AND VERIFIED
DETAILED ANSWERS|100% CORRECT
|ALREADY GRADED A
A. Apply gel after applying lotion, powder, or oil
B. Washing hands after application is not necessary
C. Allow gel to dry before dressing
D. Massage or rub in gel after application
C.
CG is a 55-year-old post-menopausal woman seeking treatment for vasomotor symptoms. She
has an intact uterus and a history of breast cancer.
Which of the following patient data is an absolute contraindication to hormone replacement
therapy?
A. Former smoker
B. Current treatment for type 2 diabetes
C. History of breast cancer
D. Family history of CHD
C.
, NAMS MENOPAUSE CERIFICATION EXAM
COMPREHENSIVE REVIEW | 2026/2027
WITH ACTUAL QUESTIONS AND VERIFIED
DETAILED ANSWERS|100% CORRECT
|ALREADY GRADED A
CG is a 55-year-old post-menopausal woman seeking treatment for vasomotor symptoms. She
has an intact uterus and a history of breast cancer.
Which treatment is most appropriate for this patient?
A. Micronized 17β- estradiol (Estrace)
B. Venlafaxine (Effexor)
C. Ospemifene (Osphena)
D. Raloxifene (Evista)
B.
HC, a 52-year-old female, has been prescribed a continuous combined oral estrogen and
progestogen product for vasomotor symptom relief related to menopause. She has read about the
potential risks associated with HRT and would like to discuss these before filling the
prescription.
COMPREHENSIVE REVIEW | 2026/2027
WITH ACTUAL QUESTIONS AND VERIFIED
DETAILED ANSWERS|100% CORRECT
|ALREADY GRADED A
JW, a 53-year-old post-menopausal female, presents to the pharmacy with a new prescription for
17β- estradiol topical gel (EstroGel) for vasomotor symptom relief.
Which of the following is the appropriate administration of 17β- estradiol topical gel (EstroGel)?
A. Apply 1 pump depression once daily to one arm from wrist to shoulder
B. Apply 1 pump depression once daily to one upper arm and shoulder area
C. Apply 1 packet once daily to one upper thigh
D. Apply 1 pouch once daily to each thigh and calf
A.
JW, a 53-year-old post-menopausal female, presents to the pharmacy with a new prescription for
17β- estradiol topical gel (EstroGel) for vasomotor symptom relief.
Which statement should be included in the counseling for 17β- estradiol topical gel (EstroGel)?
, NAMS MENOPAUSE CERIFICATION EXAM
COMPREHENSIVE REVIEW | 2026/2027
WITH ACTUAL QUESTIONS AND VERIFIED
DETAILED ANSWERS|100% CORRECT
|ALREADY GRADED A
A. Apply gel after applying lotion, powder, or oil
B. Washing hands after application is not necessary
C. Allow gel to dry before dressing
D. Massage or rub in gel after application
C.
CG is a 55-year-old post-menopausal woman seeking treatment for vasomotor symptoms. She
has an intact uterus and a history of breast cancer.
Which of the following patient data is an absolute contraindication to hormone replacement
therapy?
A. Former smoker
B. Current treatment for type 2 diabetes
C. History of breast cancer
D. Family history of CHD
C.
, NAMS MENOPAUSE CERIFICATION EXAM
COMPREHENSIVE REVIEW | 2026/2027
WITH ACTUAL QUESTIONS AND VERIFIED
DETAILED ANSWERS|100% CORRECT
|ALREADY GRADED A
CG is a 55-year-old post-menopausal woman seeking treatment for vasomotor symptoms. She
has an intact uterus and a history of breast cancer.
Which treatment is most appropriate for this patient?
A. Micronized 17β- estradiol (Estrace)
B. Venlafaxine (Effexor)
C. Ospemifene (Osphena)
D. Raloxifene (Evista)
B.
HC, a 52-year-old female, has been prescribed a continuous combined oral estrogen and
progestogen product for vasomotor symptom relief related to menopause. She has read about the
potential risks associated with HRT and would like to discuss these before filling the
prescription.
